Menu ×

HEALTHCARE & PHARMACEUTICAL

Phenylketonuria Drugs Market Segmentation by Drug Type (Palynziq, Kuvan, SYNB1618, and Others); by Route of Administration (Intravenous, Oral, and Subcutaneous); by End Users (Online Pharmacies, Hospital Pharmacies, Speciality Clinics, and Others) - Global Demand Analysis & Opportunity Outlook 2029

  • Text Size:

Extensive insights into the Growth of Phenylketonuria Drugs Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Global Phenylketonuria Drugs Market Highlights 2020-2029

The global phenylketonuria drugs market is anticipated to grow with a significant CAGR during the forecast period, i.e., 2021-2029. The growth of the market can be attributed to the rising prevalence of phenylketonuria globally and high incidence rate of the disorder in some emerging countries such as Turkey. Further, the increasing government initiatives in order to increase awareness & knowledge towards phenylketonuria treatment, along with the surge in the mergers and acquisitions between different key players for the development of new drugs is propelling demand for phenylketonuria drugs market are anticipated to drive the market growth. Moreover, rising research activities in the field of biotechnology and genomics is also anticipated to contribute to the growth of the market in the coming years.

Phenylketonuria Drugs Market

The global phenylketonuria drugs market is segmented on the basis of drug type into Palynziq, Kuvan, SYNB1618 and others. Among these segments, the Kuvan drug segment is estimated to capture the largest market share in the year 2021. Kuvan drug contains the oral pharmaceutical formulation BH4, which is known to stimulate the activity of phenylalanine hydroxylase enzyme to metabolize phenylalanine into tyrosine.

Global Phenylketonuria Drugs Market Regional Synopsis

Geographically, the global phenylketonuria drugs market is segmented into five major region including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Among the market in these regions, the market in the North America is estimated to hold largest market share by the end of 2029. The growth of the market in the region can be attributed to the rising research and development activities for novel drugs coupled with the favourable government regulations for the treatment of phenylketonuria. In addition, improvements in healthcare infrastructure in the region along with growing cases of new-born suffering from the disorder is also projected to foster the market growth. CLICK TO DOWNLOAD SAMPLE REPORT

On the other hand, the market in the Asia Pacific is anticipated to foresee significant growth on account of the rising population in emerging nations and growing awareness for the treatment of phenylketonuria. Moreover, progress in the economies along with several screening programs in the region is also estimated to accelerate the market growth over the forecast period.

Phenylketonuria Drugs Market

The phenylketonuria drugs market is further classified on the basis of region as follows:

  • North America (US, Canada, Mexico and rest of North America) Market size, Y-O-Y growth and Opportunity analysis.
  • Europe (Italy, France, Russia, Spain, Belgium, Switzerland, UK, Germany and Other parts of Europe) Market size, Y-O-Y growth and Opportunity analysis.
  • Asia Pacific (India, Malaysia, Indonesia, China, New Zealand, Philippines, Singapore, Japan, Australia and rest of Asia Pacific) Market size, Y-O-Y growth and Opportunity analysis.
  • Latin America (Argentina, Brazil, Columbia and other parts of Latin America) Market size, Y-O-Y growth and Opportunity analysis.
  • Middle East & Africa (Saudi Arabia, Israel, Egypt, United Arab Emirates, North Africa and South Africa) Market size, Y-O-Y growth and Opportunity analysis.

Market Segmentation

Our in-depth analysis of the global phenylketonuria drugs market includes the following segments:

By Drug Type

  • Palynziq
  • Kuvan
  • SYNB1618
  • Others

By Route of Administration

  • Intravenous
  • Oral
  • Subcutaneous

By End Users

  • Online Pharmacies
  • Hospital Pharmacies
  • Speciality Clinics
  • Others

Growth Drivers

  • Rising Demand for Phenylketonuria Treatment Drugs
  • Growing Advancements in Healthcare

Challenges

  • High Cost of Phenylketonuria Drugs

Top Key Players Dominating the Market

  • Ultragenyx Pharmaceutical
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
  • PTC Therapeutics
  • BioMarin
  • Homology Medicines, Inc.
  • SOM BIOTECH
  • Nestle Health Science
  • American Gene Technologies Inc.
  • Rubius Therapeutics, Inc.
  • Synlogic

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved